Bitdeer Technologies Group’s (BTDR) “Overweight” Rating Reiterated at Cantor Fitzgerald
Bitdeer Technologies Group (NASDAQ:BTDR – Get Free Report)‘s stock had its “overweight” rating restated by equities researchers at Cantor Fitzgerald in a research note issued to investors on Thursday, Benzinga reports. They presently have a $13.00 target price on the stock. Cantor Fitzgerald’s price target suggests a potential upside of 78.08% from the company’s previous […]
Molina Healthcare (NYSE:MOH) Earns “Overweight” Rating from Cantor Fitzgerald
Cantor Fitzgerald reissued their overweight rating on shares of Molina Healthcare (NYSE:MOH – Free Report) in a research note released on Tuesday, Benzinga reports. Cantor Fitzgerald currently has a $406.00 price objective on the stock. Other analysts have also recently issued research reports about the stock. JPMorgan Chase & Co. lowered their target price on […]
Elevance Health (NYSE:ELV) Earns “Overweight” Rating from Cantor Fitzgerald
Cantor Fitzgerald restated their overweight rating on shares of Elevance Health (NYSE:ELV – Free Report) in a report published on Tuesday, Benzinga reports. Cantor Fitzgerald currently has a $600.00 target price on the stock. Several other equities research analysts have also issued reports on ELV. Barclays reduced their price target on Elevance Health from $621.00 […]
Merck & Co., Inc.’s (MRK) “Overweight” Rating Reiterated at Cantor Fitzgerald
Cantor Fitzgerald reiterated their overweight rating on shares of Merck & Co., Inc. (NYSE:MRK – Free Report) in a research report released on Thursday, Benzinga reports. Cantor Fitzgerald currently has a $155.00 target price on the stock. Cantor Fitzgerald also issued estimates for Merck & Co., Inc.’s FY2024 earnings at $7.66 EPS. A number of […]
Cantor Fitzgerald Reaffirms Overweight Rating for Progyny (NASDAQ:PGNY)
Cantor Fitzgerald reaffirmed their overweight rating on shares of Progyny (NASDAQ:PGNY – Free Report) in a research report released on Tuesday, Benzinga reports. The firm currently has a $25.00 price objective on the stock. A number of other brokerages have also commented on PGNY. Jefferies Financial Group cut their price target on Progyny from $31.00 […]
Cipher Mining (NASDAQ:CIFR) Given Overweight Rating at Cantor Fitzgerald
Cantor Fitzgerald reiterated their overweight rating on shares of Cipher Mining (NASDAQ:CIFR – Free Report) in a research report released on Thursday, Benzinga reports. They currently have a $9.00 price target on the stock. Other analysts also recently issued reports about the company. HC Wainwright upped their price objective on Cipher Mining from $5.50 to […]
Surgery Partners (NASDAQ:SGRY) Stock Rating Reaffirmed by Cantor Fitzgerald
Surgery Partners (NASDAQ:SGRY – Get Free Report)‘s stock had its “overweight” rating reaffirmed by Cantor Fitzgerald in a research note issued on Friday, Benzinga reports. They presently have a $43.00 target price on the stock. Cantor Fitzgerald’s target price would indicate a potential upside of 38.00% from the stock’s current price. A number of other […]
last updated on 6 Oct 13:26